Complement. Second of two parts.
暂无分享,去创建一个
[1] M. Pepys. Cambridge University Natural Science Club, 1872 to 1972 , 1972, Nature.
[2] M. Pepys. ROLE OF COMPLEMENT IN INDUCTION OF ANTIBODY PRODUCTION IN VIVO , 1974, The Journal of experimental medicine.
[3] A. J. Mcadams,et al. Lupus-erythematosus-like disease in three unrelated women with hereditary angioneurotic edema. , 1977, Annals of internal medicine.
[4] M. Pepys,et al. Amyloid P component binds to keratin bodies in human skin and to isolated keratin filament aggregates in vitro. , 1988, The Journal of investigative dermatology.
[5] M. Pepys,et al. Serum amyloid P component binds to cell nuclei in vitro and to in vivo deposits of extracellular chromatin in systemic lupus erythematosus , 1989, The Journal of experimental medicine.
[6] T. Mack,et al. A revised estimate of twin concordance in systemic lupus erythematosus. , 1992, Arthritis and rheumatism.
[7] W. Dreyer,et al. Cardiolipin-protein complexes and initiation of complement activation after coronary artery occlusion. , 1994, Circulation research.
[8] Christopher C. Goodnow,et al. C3d of Complement as a Molecular Adjuvant: Bridging Innate and Acquired Immunity , 1996, Science.
[9] D. Fearon,et al. Activation of B lymphocytes: integrating signals from CD19, CD22 and FcγRIIb1 , 1996 .
[10] D. Mevorach,et al. Complement-dependent Clearance of Apoptotic Cells by Human Macrophages , 1998, The Journal of experimental medicine.
[11] Jianzhu Chen,et al. A Critical Role of Natural Immunoglobulin M in Immediate Defense Against Systemic Bacterial Infection , 1998, The Journal of experimental medicine.
[12] M. Pepys,et al. C-Reactive Protein and Complement Are Important Mediators of Tissue Damage in Acute Myocardial Infarction , 1999, The Journal of experimental medicine.
[13] M. Kazatchkine,et al. Autoantibodies against C1q: view on clinical relevance and pathogenic roles , 1999, Clinical and experimental immunology.
[14] P. Butler,et al. Serum amyloid P component controls chromatin degradation and prevents antinuclear autoimmunity , 1999, Nature Medicine.
[15] L. Herzenberg,et al. Innate and acquired humoral immunities to influenza virus are mediated by distinct arms of the immune system. , 1999, Proceedings of the National Academy of Sciences of the United States of America.
[16] Yuan Zhang,et al. Neuronal protection in stroke by an sLex-glycosylated complement inhibitory protein. , 1999, Science.
[17] P. Taylor,et al. Systemic lupus erythematosus, complement deficiency, and apoptosis. , 2000, Advances in immunology.
[18] S. Meri,et al. Complement activation after oxidative stress: role of the lectin complement pathway. , 2000, The American journal of pathology.
[19] N. Brot,et al. C-Reactive Protein Binds to Apoptotic Cells, Protects the Cells from Assembly of the Terminal Complement Components, and Sustains an Antiinflammatory Innate Immune Response , 2000, The Journal of experimental medicine.
[20] T. Fujita,et al. Cutting Edge: Complement-Activating Complex of Ficolin and Mannose-Binding Lectin-Associated Serine Protease1 , 2000, The Journal of Immunology.
[21] T. Möröy,et al. Features of systemic lupus erythematosus in Dnase1-deficient mice , 2000, Nature Genetics.
[22] Jianzhu Chen,et al. Accelerated development of IgG autoantibodies and autoimmune disease in the absence of secreted IgM. , 2000, Proceedings of the National Academy of Sciences of the United States of America.
[23] M. Carroll,et al. The role of complement in B cell activation and tolerance. , 2000, Advances in immunology.
[24] A hierarchical role for classical pathway complement proteins in the clearance of apoptotic cells in vivo. , 2000 .
[25] M. Neuberger,et al. Deficiency in Serum Immunoglobulin (Ig)m Predisposes to Development of Igg Autoantibodies , 2000, The Journal of experimental medicine.
[26] B. Heyman,et al. Regulation of antibody responses via antibodies, complement, and Fc receptors. , 2000, Annual review of immunology.